Literature DB >> 27041116

Molecular genetic analysis in 93 patients and 193 family members with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Croatia.

Katja K Dumic1, Zorana Grubic2, Tony Yuen3, Robert C Wilson4, Vesna Kusec5, Ingeborg Barisic6, Katarina Stingl2, Ivona Sansovic6, Veselin Skrabic7, Miroslav Dumic8, Maria I New3.   

Abstract

Congenital adrenal hyperplasia owing to 21-hydroxylase deficiency is caused by mutation in the CYP21A2 gene. The frequency and spectrum of CYP21A2 mutations and genotype-phenotype correlations among different populations are variable. Aim of this study was to define mutation frequency and spectrum of CYP21A2 gene mutations in patients with classical 21-hydroxylase deficiency (21OHD) and their family members in Croatia and study genotype-phenotype correlation. Clinical features and mutations of CYP21A2 gene in 93 unrelated 21OHD patients and 193 family members were examined. In this cohort, 66 patients were affected with salt wasting (SW) form, and 27 were affected with simple virilizing (SV) form of the disease. Mutations were identified in both alleles (67% compound heterozygous and 33% homozygous) in 91 of 93 patients. Deletions and conversions were found in 18.8% and point mutations in 79.6% alleles. Mutations in 3 alleles (1.6%) remained unidentified (in one patient we found only one, while in other no mutations were found at all). The most common point mutations were Intron 2 splice mutation IVS2-13 A/C>G (35.5%) and p.R357W (16.7%). Genotypes were categorized into Groups 0, A, B and C according to the extent of enzyme impairment. Genotype-phenotype concordance was 100%, 85% and 75% for Groups 0, A and B, respectively. Since only classical 21OHD patients were studied, Group C comprised solely p.P31L mutation and had 73% patients with SV and 27% with SW phenotype. Intrafamilial phenotypic variability was found in two families. CYP21A2 genetic analysis in 193 family members showed that 126 parents were heterozygous carriers, 3 were newly discovered patients, 2 fathers were not biological parents, and mutations were not detected in 3. Among 59 siblings, 32 were heterozygous carriers, 15 carried normal alleles, and 12 were patients (4 newly diagnosed). Genotype-phenotype divergence observed in this study suggests caution in preconceptional counseling and prenatal diagnosis of CAH. High frequency of p.R357W mutation was found in Croatian patients with classical 21-OHD. Genotyping of family members discovered new patients and thus avoided pitfalls in genetic counseling when the parents were found to be affected. Copyright Â
© 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  21-Hydroxylase deficiency; CYP21A2 gene; Genotype; Phenotype

Mesh:

Substances:

Year:  2016        PMID: 27041116     DOI: 10.1016/j.jsbmb.2016.03.035

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  10 in total

1.  Development of CYP21A2 Genotyping Assay for the Diagnosis of Congenital Adrenal Hyperplasia.

Authors:  Mayara Jorgens Prado; Simone Martins de Castro; Cristiane Kopacek; Maricilda Palandi de Mello; Thaiane Rispoli; Tarciana Grandi; Cláudia Maria Dornelles da Silva; Maria Lucia Rosa Rossetti
Journal:  Mol Diagn Ther       Date:  2017-12       Impact factor: 4.074

2.  Molecular diagnosis of Chinese patients with 21-hydroxylase deficiency and analysis of genotype-phenotype correlations.

Authors:  Bo Zhang; Lin Lu; Zhaolin Lu
Journal:  J Int Med Res       Date:  2017-02-02       Impact factor: 1.671

3.  CONGENITAL ADRENAL HYPERPLASIA WITH COMPOUND HETEROZYGOUS I2 SPLICE AND P453S MUTATIONS.

Authors:  B Almacan; N Ozdemir; H Onay; Z Hekimsoy
Journal:  Acta Endocrinol (Buchar)       Date:  2022 Apr-Jun       Impact factor: 1.104

4.  Prenatal diagnosis of steroid 21-hydroxylase-deficient congenital adrenal hyperplasia: Experience from a tertiary care centre in India.

Authors:  Sudhisha Dubey; Veronique Tardy; Madhumita Roy Chowdhury; Neerja Gupta; Vandana Jain; Deepika Deka; Pankaj Sharma; Yves Morel; Madhulika Kabra
Journal:  Indian J Med Res       Date:  2017-02       Impact factor: 2.375

Review 5.  Clinical outcomes and characteristics of P30L mutations in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  Mirjana Kocova; Violeta Anastasovska; Henrik Falhammar
Journal:  Endocrine       Date:  2020-05-05       Impact factor: 3.633

Review 6.  Characteristics of In2G Variant in Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency.

Authors:  Mirjana Kocova; Paola Concolino; Henrik Falhammar
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-24       Impact factor: 5.555

7.  Congenital adrenal hyperplasia with homozygous and heterozygous mutations: a rare family case report.

Authors:  Tiantian Cheng; Jing Liu; Wenwen Sun; Guangyao Song; Huijuan Ma
Journal:  BMC Endocr Disord       Date:  2022-03-07       Impact factor: 2.763

8.  Molecular analysis and genotype-phenotype correlations in patients with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency from southern Poland - experience of a clinical center.

Authors:  Anna Kurzyńska; Anna Skalniak; Kim Franson; Viola Bistika; Alicja Hubalewska-Dydejczyk; Elwira Przybylik-Mazurek
Journal:  Hormones (Athens)       Date:  2022-01-26       Impact factor: 3.419

9.  Syrian females with congenital adrenal hyperplasia: a case series.

Authors:  Nada Dehneh; Rami Jarjour; Sahar Idelbi; Assad Alibrahem; Sahar Al Fahoum
Journal:  J Med Case Rep       Date:  2022-10-15

10.  Genetic aetiology of primary adrenal insufficiency in Chinese children.

Authors:  Zhuo Chang; Wei Lu; Zhuhui Zhao; Li Xi; Xiaojing Li; Rong Ye; Jinwen Ni; Zhou Pei; Miaoying Zhang; Ruoqian Cheng; Zhangqian Zheng; Chengjun Sun; Jing Wu; Feihong Luo
Journal:  BMC Med Genomics       Date:  2021-06-30       Impact factor: 3.063

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.